US 6,555,548 B2Granted

Compounds for treating fibromyalgia and chronic fatigue syndrome

AssigneePharmacia & Upjohn Company

InventorsRobert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley

Life of this patent

Estimating the term…

Abstract

The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.

Claims4

Dependent claims

A method of treating the symptoms of fibromyalgia syndrome or chronic fatigue syndrome, comprising administering to a patient in need of treatment a therapeutically effective amount of an active agent selected from the group consisting of a cabergoline-type compound and pharmaceutically acceptable salts of said compound.

Dependencies are inferred from the claim text.

Facts

Application: 10/159,913Filed 30 May 2002 · division
Priority: 21 Apr 2000
Published: US 2002/0004510 A13 Oct 2002
Granted: 29 Apr 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61K 31/451
Non condensed piperidines, e.g. piperocaine: having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine,…
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/48
Quinolines; Isoquinolines: ergoline derivatives, e.g. lysergic acid, ergotamine

Family

Application60/198,959Us provisional application · filed 21 Apr 2000
Application60/200,569Us provisional application · filed 28 Apr 2000
Application09/836,660Parent of this division · filed 17 Apr 2001
US 2002/0143010 A1Pre-grant publication · published 3 Oct 2002
US 6,448,258 B2Parent of this division
US 2002/0004510 A1Published application
US 6,555,548 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Abstract

The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.

Facts

Application

10/159,913Filed 30 May 2002 · division

Priority

21 Apr 2000

Published

US 2002/0004510 A13 Oct 2002

Granted

29 Apr 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61K 31/451
Non condensed piperidines, e.g. piperocaine: having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine,…
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/48
Quinolines; Isoquinolines: ergoline derivatives, e.g. lysergic acid, ergotamine

Family

Application60/198,959Us provisional application · filed 21 Apr 2000

Application60/200,569Us provisional application · filed 28 Apr 2000

Application09/836,660Parent of this division · filed 17 Apr 2001

US 2002/0143010 A1Pre-grant publication · published 3 Oct 2002

US 6,448,258 B2Parent of this division

US 2002/0004510 A1Published application

US 6,555,548 B2This patent

From the US filing history. Foreign family members aren’t listed.